Accent MicrocellNSE:ACCENTMIC -1.00%19 Net Margin % is 12.50% as of Mar. 2025, which is 102% above its 10-year median of 6.20. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 953 Drug Manufacturers companies, Accent Microcell ranks better than 71.88% on this metric.
The historical rank and industry rank for Accent Microcell's Net Margin % or its related term are showing as below:
NSE:ACCENTMIC'
s Net Margin % Range Over the Past 10 Years
Min: 3.56 Med: 6.2 Max: 12.5
Current: 12.5
NSE:ACCENTMIC's Net Margin % is ranked better than 71.88% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs NSE:ACCENTMIC: 12.50
Accent Microcell (NSE:ACCENTMIC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Accent Microcell Net Margin % Related Terms
Accent Microcell Net Margin % Historical Data
* Premium members only.
The historical data trend for Accent Microcell's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell Net Margin % Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Net Margin %
3.62
3.56
6.20
12.29
12.50
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Net Margin %
3.62
3.56
6.20
12.29
12.50
NSE:ACCENTMIC vs ZTS, UTHR: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Net Margin % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell (NSE:ACCENTMIC) has a Net Margin % of 12.50% as of Mar. 2025. Net margin is the ratio of total net income to net sales. View historical data on Accent Microcell and its competitors. This is 102% above median its historical median of 6.20. Over the past decade, Accent Microcell's Net Margin % has ranged from 3.56 to 12.50. According to the industry distribution chart, Accent Microcell ranks #268 out of 953 companies in the Drug Manufacturers industry, placing it in the top 28.1%.
Is Accent Microcell's Net Margin % too high?
Accent Microcell's current Net Margin % of 12.50% is 102% above median its 10-year median of 6.20. Over the past 10 years, this metric has ranged from a low of 3.56 to a high of 12.50. The Drug Manufacturers industry median Net Margin % is 5.69. Accent Microcell's value of 12.50% is 119.7% above this industry median. Based on the distribution chart, Accent Microcell ranks #268 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #268 out of 953 companies for Net Margin %. This puts Accent Microcell in the upper half of its industry. The industry median Net Margin % is 5.69. Accent Microcell's value of 12.50% is 119.7% above this benchmark. Historically, Accent Microcell's own Net Margin % has ranged from 3.56 to 12.50 over the past decade. While the company's 10-year median is 6.20 vs. the industry median of 5.69, Accent Microcell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current Net Margin % of 12.50% is 119.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current Net Margin % is 12.50%, which is 102% above median its own 10-year median of 6.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Net Margin % of 12.50%. The current Net Margin % is 12.50%, which is 102% above median its 10-year median of 6.20 and 119.7% above the Drug Manufacturers industry median of 5.69. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Net Margin % is 12.50% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score
Get the complete analysis for NSE:ACCENTMIC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 